For almost 75 years the International Union Against Cancer (UICC) has been the only international non-governmental organisation dedicated exclusively to the global control of cancer. But with many societies currently going global’, including ASCO and [more]
More and more cancer patients are using the Internet to find out about their disease and treatment, to seek support from online patient communities and to communicate with their professional carers and loved ones. However, [more]
Late last year, US patients with advanced renal cell cancer gained access to an oral multi-kinase inhibitor, Nexavar (sorafinib) the first new drug approved for this disease in the last 10 years. Manufacturer Bayer [more]
Decades of experience have taught us to guard against the temptation to trumpet early impressive results as breakthroughs. Yet some of the comments over the promising results from trials testing Herceptin (trastuzumab) in early-stage breast [more]
Disparities in the speed at which patients in different European countries get access to the latest cancer drugs were highlighted last month in a report published by Stockholm’s Karolinska Institute. The Roche-sponsored study, launched at [more]
Every two years, doctors specialising in breast cancer gather in St Gallen to discuss developments and update guidelines on adjuvant therapies. It is always an important conference, but its conclusions tend to be measured rather [more]
An opportunity is opening up for Europe’s cancer community to increase its influence over health and research policies, by overcoming its fragmentation to speak with a single voice. Download full article
When Pfizer followed Merck & co in withdrawing one of their COX-2 inhibitors from the market owing to increased risks of cardiovascular complications, it provided a timely reminder that medicines are not without their risks. [more]
Blogging a novel form of Internet communication is starting to enter the cancer world. A blogger’ is someone who posts their thoughts and opinions to an online journal (called a web log’ or [more]
Ninety-six of every 100 adult cancer patients do not enrol in a clinical trial. One reason is that many trials are shrouded in a veil of secrecy, and patients find it hard to locate one [more]